{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Eligible",
      "product_code": "PTD",
      "openfda": {
        "k_number": [
          "K163001",
          "K191143",
          "K192291"
        ],
        "registration_number": [
          "3006082230",
          "1450392",
          "9617592",
          "3006260740",
          "1018233"
        ],
        "fei_number": [
          "3006082230",
          "1450392",
          "3002468371",
          "3006260740",
          "1018233"
        ]
      },
      "review_panel": "HO",
      "medical_specialty": "HO",
      "device_name": "Subcutaneous Implanted Apheresis Port",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "General Hospital",
      "device_class": "2",
      "definition": "A subcutaneous implanted apheresis port is a prescription device intended for patient therapies requiring repeated access to the vascular system and long-term therapeutic apheresis",
      "regulation_number": "880.5965",
      "implant_flag": "Y",
      "submission_type_id": "1"
    }
  ]
}